1. Home
  2. IROQ vs UNCY Comparison

IROQ vs UNCY Comparison

Compare IROQ & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROQ
  • UNCY
  • Stock Information
  • Founded
  • IROQ 1883
  • UNCY 2016
  • Country
  • IROQ United States
  • UNCY United States
  • Employees
  • IROQ N/A
  • UNCY N/A
  • Industry
  • IROQ Savings Institutions
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • IROQ Finance
  • UNCY Health Care
  • Exchange
  • IROQ Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • IROQ 82.7M
  • UNCY 74.2M
  • IPO Year
  • IROQ 2011
  • UNCY 2021
  • Fundamental
  • Price
  • IROQ $25.60
  • UNCY $3.94
  • Analyst Decision
  • IROQ
  • UNCY Strong Buy
  • Analyst Count
  • IROQ 0
  • UNCY 5
  • Target Price
  • IROQ N/A
  • UNCY $55.20
  • AVG Volume (30 Days)
  • IROQ 1.5K
  • UNCY 520.0K
  • Earning Date
  • IROQ 11-03-2025
  • UNCY 11-12-2025
  • Dividend Yield
  • IROQ 1.56%
  • UNCY N/A
  • EPS Growth
  • IROQ 139.63
  • UNCY N/A
  • EPS
  • IROQ 1.37
  • UNCY N/A
  • Revenue
  • IROQ $26,459,000.00
  • UNCY N/A
  • Revenue This Year
  • IROQ N/A
  • UNCY N/A
  • Revenue Next Year
  • IROQ N/A
  • UNCY $4,481.14
  • P/E Ratio
  • IROQ $18.74
  • UNCY N/A
  • Revenue Growth
  • IROQ 19.82
  • UNCY N/A
  • 52 Week Low
  • IROQ $18.36
  • UNCY $3.40
  • 52 Week High
  • IROQ $25.97
  • UNCY $11.00
  • Technical
  • Relative Strength Index (RSI)
  • IROQ 63.23
  • UNCY 37.53
  • Support Level
  • IROQ $25.50
  • UNCY $4.23
  • Resistance Level
  • IROQ $25.63
  • UNCY $4.43
  • Average True Range (ATR)
  • IROQ 0.25
  • UNCY 0.19
  • MACD
  • IROQ 0.01
  • UNCY -0.01
  • Stochastic Oscillator
  • IROQ 81.68
  • UNCY 22.22

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: